Skip to main content
HIV treatment and prevention using broadly neutralizing antibodies

HIV treatment and prevention using broadly neutralizing antibodies

Unmet Need For over 40 years, the HIV pandemic has affected millions, reducing life expectancy and quality of life. As of 2021, 38.4 million people globally are living with HIV, with about 1.5 million new…

Read More

Identification and application of novel lipoglycodepsipeptide antibiotics

Identification and application of novel lipoglycodepsipeptide antibiotics

Unmet Need Antibiotic resistance (ABR) is a global public health concern. In 2019, an estimated five million deaths were attributed to antibiotic resistant pathogens. A recent study estimates that ABR could cause nearly ten million…

Read More

Universal Antibodies Effective Against Both Influenza A and B

Universal Antibodies Effective Against Both Influenza A and B

Unmet Need Distinct influenza A and B viruses (IAV and IBV) circulate in human populations, causing significant widespread morbidity. Antibodies (Abs) that bind epitopes conserved in both IAV and IBV hemagglutinins (HAs) could protect against…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us